4.4 Review

Ketamine for the treatment of mental health and substance use disorders: comprehensive systematic review

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Psychiatry

This Is Something That Changed My Life: A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders

O. Merve Mollaahmetoglu et al.

Summary: This study explored participant experiences of ketamine infusions in a clinical trial setting and how these experiences relate to therapeutic mechanisms. The acute experiences of participants included contradictions, rapid fluctuations, and meaningful experiences. Ketamine treatment in a supportive environment led to significant changes in participants' relationship with alcohol, indicating the transformative effects of ketamine in therapeutic settings.

FRONTIERS IN PSYCHIATRY (2021)

Review Clinical Neurology

Anorexia nervosa, zinc deficiency and the glutamate system: The ketamine option

Daniel F. Hermens et al.

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2020)

Review Pharmacology & Pharmacy

Hippocampal volume, function, and related molecular activity in anorexia nervosa: A scoping review

Johanna Keeler et al.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)

Article Psychology, Clinical

Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis

George Papakostas et al.

JOURNAL OF CLINICAL PSYCHIATRY (2020)

Review Clinical Neurology

The effect of intravenous, intranasal, and oral ketamine in mood disorders: A meta-analysis

Roger S. McIntyre et al.

JOURNAL OF AFFECTIVE DISORDERS (2020)

Review Medicine, General & Internal

Treatments for the Prevention and Management of Suicide A Systematic Review

Kristen E. D'Anci et al.

ANNALS OF INTERNAL MEDICINE (2019)

Review Psychology, Clinical

Oral Ketamine for Depression: A Systematic Review

Joshua D. Rosenblat et al.

JOURNAL OF CLINICAL PSYCHIATRY (2019)

Article Neurosciences

Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

Jerome H. Taylor et al.

NEUROPSYCHOPHARMACOLOGY (2018)

Article Neurosciences

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

R. L. Carhart-Harris et al.

PSYCHOPHARMACOLOGY (2018)

Article Anesthesiology

Ketamine-based anesthesia improves electroconvulsive therapy outcomes: a randomized-controlled study

Jonathan J. Gamble et al.

CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE (2018)

Article Critical Care Medicine

Adjunct Ketamine Use in the Management of Severe Ethanol Withdrawal

Anthony F. Pizon et al.

CRITICAL CARE MEDICINE (2018)

Article Clinical Neurology

Ketamine Effects on EEG during Therapy of Treatment-Resistant Generalized Anxiety and Social Anxiety

Shabah Mohammad Shadli et al.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2018)

Article Clinical Neurology

A randomized clinical trial of adjunctive ketamine anesthesia in electroconvulsive therapy for depression

Minling Zhang et al.

JOURNAL OF AFFECTIVE DISORDERS (2018)

Article Anesthesiology

Ketamine Anesthesia Does Not Improve Depression Scores in Electroconvulsive Therapy: A Randomized Clinical Trial

Charles William Carspecken et al.

JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY (2018)

Review Clinical Neurology

Addictive potential of novel treatments for refractory depression and anxiety

Dusan Kolar

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)

Review Clinical Neurology

A review of ketamine's role in ECT and non-ECT settings

Vytautas Jankauskas et al.

NEUROPSYCHIATRIC DISEASE AND TREATMENT (2018)

Review Clinical Neurology

Efficacy of off-label augmentation in unipolar depression: A systematic review of the evidence

Julia Kleeblatt et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)

Review Clinical Neurology

Investigational drugs in recent clinical trials for treatment-resistant depression

Ricardo P. Garay et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)

Review Psychiatry

Administration of ketamine for unipolar and bipolar depression

Christoph Kraus et al.

INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE (2017)

Article Clinical Neurology

Effect of ketamine dose on self-rated dissociation in patients with treatment refractory anxiety disorders

Cameron Castle et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2017)

Article Neurosciences

The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future

Robin L. Carhart-Harris et al.

NEUROPSYCHOPHARMACOLOGY (2017)

Article Behavioral Sciences

Ketamine as a rapid-acting agent for suicidal ideation: A meta-analysis

Francesco Bartoli et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)

Review Clinical Neurology

Investigational drugs in recent clinical trials for treatment-resistant depression

Ricardo P. Garay et al.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2017)

Review Psychiatry

Efficacy and safety of ketamine in bipolar depression: A systematic review

Susana Alberich et al.

REVISTA DE PSIQUIATRIA Y SALUD MENTAL (2017)

Article Psychiatry

Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial

Gordon Fernie et al.

BRITISH JOURNAL OF PSYCHIATRY (2017)

Review Psychiatry

How do antidepressants work? New perspectives for refining future treatment approaches

Catherine J. Harmer et al.

LANCET PSYCHIATRY (2017)

Article Public, Environmental & Occupational Health

The role of socio-economic status in depression: results from the COURAGE (aging survey in Europe)

Aislinne Freeman et al.

BMC PUBLIC HEALTH (2016)

Letter Psychology, Clinical

Can Exposure-Based CBT Extend the Effects of Intravenous Ketamine in Obsessive-Compulsive Disorder? An Open-Label Trial

Carolyn I. Rodriguez et al.

JOURNAL OF CLINICAL PSYCHIATRY (2016)

Article Medicine, General & Internal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Medicine, General & Internal

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A. C. Sterne et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Review Clinical Neurology

The use of ketamine as an antidepressant: a systematic review and meta-analysis

Caoimhe M. Coyle et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2015)

Review Pharmacology & Pharmacy

Ketamine as a Potential Treatment for Suicidal Ideation: A Systematic Review of the Literature

Lael Reinstatler et al.

DRUGS IN R&D (2015)

Article Pharmacology & Pharmacy

Evaluation of Adjunctive Ketamine to Benzodiazepines for Management of Alcohol Withdrawal Syndrome

Adrian Wong et al.

ANNALS OF PHARMACOTHERAPY (2015)

Article Psychiatry

Antidepressant Effect of Combined Ketamine and Electroconvulsive Therapy on Patients With Major Depressive Disorder: A Randomized Trial

Narges Alizadeh et al.

IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES (2015)

Article History

Salvador Roquet, Maria Sabina, and the Trouble with Jipis

Alexander S. Dawson

HAHR-HISPANIC AMERICAN HISTORICAL REVIEW (2015)

Review Neurosciences

The Role of Ketamine in Treatment-Resistant Depression: A Systematic Review

Gianluca Serafini et al.

CURRENT NEUROPHARMACOLOGY (2014)

Article Neurosciences

Ketamine as Antidepressant? Current State and Future Perspectives

H. W. W. Hasselmann

CURRENT NEUROPHARMACOLOGY (2014)

Article Substance Abuse

Therapeutic infusions of ketamine: Do the psychoactive effects matter?

E. Dakwar et al.

DRUG AND ALCOHOL DEPENDENCE (2014)

Article Clinical Neurology

Do the dissociative side effects of ketamine mediate its antidepressant effects?

David A. Luckenbaugh et al.

JOURNAL OF AFFECTIVE DISORDERS (2014)

Review Neurosciences

Ketamine administration in depressive disorders: a systematic review and meta-analysis

Guillaume Fond et al.

PSYCHOPHARMACOLOGY (2014)

Article Psychiatry

Pilot dose-response trial of i.v. ketamine in treatment-resistant depression

Rosalyn Lai et al.

WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2014)

Article Pharmacology & Pharmacy

Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy

Caroline Caddy et al.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2014)

Review Psychiatry

Ketamine as a new treatment for depression: A review of its efficacy and adverse effects

Natalie Katalinic et al.

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)

Article Neurosciences

Randomized Controlled Crossover Trial of Ketamine in Obsessive-Compulsive Disorder: Proof-of-Concept

Carolyn I. Rodriguez et al.

NEUROPSYCHOPHARMACOLOGY (2013)

Article Pharmacology & Pharmacy

Intravenous Ketamine for Treatment-Resistant Major Depressive Disorder

Jordan R. Covvey et al.

ANNALS OF PHARMACOTHERAPY (2012)

Article Neurosciences

Effects of Ketamine in Treatment-Refractory Obsessive-Compulsive Disorder

Michael H. Bloch et al.

BIOLOGICAL PSYCHIATRY (2012)

Review Neurosciences

Ketamine for Depression: Where Do We Go from Here?

Marije Aan Het Rot et al.

BIOLOGICAL PSYCHIATRY (2012)

Article Clinical Neurology

Neuropsychological and mood effects of ketamine in electroconvulsive therapy: A randomised controlled trial

Colleen K. Loo et al.

JOURNAL OF AFFECTIVE DISORDERS (2012)

Article Clinical Neurology

Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study

Laura Kranaster et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2011)

Article Medicine, General & Internal

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Julian P. T. Higgins et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Psychiatry

A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression

Nancy Diazgranados et al.

ARCHIVES OF GENERAL PSYCHIATRY (2010)

Article Clinical Neurology

Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims

M. Schoenenberg et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2008)

Article Critical Care Medicine

The correlation between ketamine and posttraumatic stress disorder in burned service members

Laura L. McGhee et al.

JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2008)

Article Psychology, Clinical

Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence

Evgeny M. Krupitsky et al.

JOURNAL OF PSYCHOACTIVE DRUGS (2007)

Article Psychiatry

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Carlos A. Zarate et al.

ARCHIVES OF GENERAL PSYCHIATRY (2006)

Article Neurosciences

Antidepressant effects of ketamine in depressed patients

RM Berman et al.

BIOLOGICAL PSYCHIATRY (2000)